Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).

a Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, USA b Department of Neurology, Oregon Health & Science University, Portland, USA c Molecular Neurosciences, Developmental Neurosciences Programme, UCL Institute of Child Health, London, UK d Department of Physiatry, Children's Healthcare of Atlanta, GA, USA e Department of Child Neurology, The Children's Memorial Health Institute, Warsaw, Poland f NBIA Disorders Association, El Cajon, CA, USA g Hoffunngsbaum e.V., Velbert, Germany h AISNAF – Associazione Italiana Sindromi Neurodegenerative Da Accumulo Di Ferro, Rossano, Italy i Science Compass, Milano, Italy j Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany k German Center for Neurodegenerative Diseases (DZNE), Munich, Germany l Munich Cluster for Systems Neurology (SyNergy), Munich, Germany m Department of Pediatric Neuroscience, IRCCS Foundation Neurological Institute C. Besta, Milan, Italy